Danish multicenter study confirms clinical utility of genomic test in identifying low-risk stage I–II melanoma patients, advancing precision in surgical decision-making ...
St. David's Medical Center pioneers clinical use of innovative wireless EP solution, marking a new chapter in minimally invasive cardiac care....
Innovative pressure-sensing technology now in use at leading New Jersey pain management clinic, enhancing safety and precision in epidural procedures...
Next-Generation Oscillating System Enhances Precision and Protects Delicate Tissue in Spine and Cranial Procedures...
Award Recognizes HemoSonics’ Innovative Contributions and Exceptional Support in Advancing Diagnostic Hemostasis Solutions Across Premier’s Member Network...
Landmark trial to evaluate world’s first autonomous, electronic artificial urinary sphincter for stress urinary incontinence in men...
Next-Generation Platform Enhances Endoscopic Ultrasound Imaging to Support More Accurate and Efficient Diagnoses...
The FDA approval of Thermo Fisher’s Oncomine Dx Express Test marks a key advancement in precision oncology, enabling fast, accurate detection of EGFR exon 20 insertion mutations and guiding NSCLC patients to targeted treatments like ZEGFROVY....
Pivotal U.S. Trial Evaluates Safety and Effectiveness of Onyx™ for Managing Bleeding in Peripheral Vasculature...
New Platform Offers Three Genomic Tests to Tailor Treatment Strategies for Glioblastoma Patients ...
